RSC advances
Red-emitting chemosensor detects superoxide anion in models of myocardial hypertrophy
By Guo F, Liu Y, Chen Q and 1 others.
Abstract
Cardiac hypertrophy is a compensatory pathological alteration of the heart in response to prolonged stress, for which suitable diagnostic methods are lacking. Superoxide anion (O2˙-) levels are considered to be elevated during the progression of this disease. A red-emitting fluorescent chemosensor DO was rationally designed and synthesized. It enabled sensitive and accurate detection of O2˙- in solution, with a low limit of detection (LOD) of 93 nM. Chemosensor DO detected the increase in O2˙- concentration induced by angiotensin II (Ang II) in vitro and showed that losartan antagonizes Ang II-induced O2˙- production. Chemosensor DO was applied to detect elevated superoxide levels in heart tissue sections from hypertrophic mice. Therefore, this probe provides a new perspective for understanding the pathogenesis of cardiac hypertrophy.
Source
Published in RSC advances. The abstract is shown as published and remains the work of its authors; read the full article at the source.
Prognia lists this article for reference and education. It is not medical advice. Always read the original and follow current guidelines and local protocols before acting on it.
At a glance
- Journal
- RSC advances






